| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.07▼ | 2.08▼ | 2.10▼ | 2.16▼ | 2.18▼ |
| MA10 | 2.11▼ | 2.12▼ | 2.12▼ | 2.21▼ | 2.13▼ |
| MA20 | 2.13▼ | 2.15▼ | 2.17▼ | 2.19▼ | 2.24▼ |
| MA50 | 2.17▼ | 2.21▼ | 2.24▼ | 2.13▼ | 2.65▼ |
| MA100 | 2.24▼ | 2.23▼ | 2.21▼ | 2.27▼ | 2.81▼ |
| MA200 | 2.25▼ | 2.17▼ | 2.14▼ | 2.60▼ | 3.73▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.007▼ | -0.008▼ | -0.011▼ | -0.017▼ | 0.031▲ |
| RSI | 32.455▼ | 35.224▼ | 34.604▼ | 42.862▼ | 41.840▼ |
| STOCH | 6.571▼ | 24.245 | 16.224▼ | 28.191 | 62.918 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -90.244▼ | -55.597 |
| CCI | -114.636▼ | -147.769▼ | -131.833▼ | -82.688 | 15.359 |
|
Friday, August 08, 2025 04:44 AM
Kiora Pharmaceuticals develops medicines for eye diseases that can cause blindness, particularly retinal degenerative diseases where few treatment options exist. Its lead product candidate, KIO-301, ...
|
|
Wednesday, July 16, 2025 09:00 AM
Kiora Pharmaceuticals, Inc. (KPRX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates ...
|
|
Tuesday, March 25, 2025 04:30 AM
KIORA PHARMACEUTICALS ($KPRX) posted quarterly earnings results on Tuesday, March 25th. The company reported earnings of -$1.04 per share, missing estimates of -$0.56 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/02/26 | 2.12 | 2.19 | 2.06 | 2.06 | 77,066 |
| 11/02/26 | 2.2314 | 2.2314 | 2.07 | 2.14 | 98,306 |
| 10/02/26 | 2.23 | 2.26 | 2.22 | 2.25 | 28,600 |
| 09/02/26 | 2.15 | 2.24 | 2.13 | 2.22 | 86,300 |
| 06/02/26 | 2.13 | 2.175 | 2.10 | 2.15 | 42,855 |
| 05/02/26 | 2.22 | 2.23 | 2.10 | 2.12 | 78,953 |
| 04/02/26 | 2.2701 | 2.2701 | 2.16 | 2.19 | 41,338 |
| 03/02/26 | 2.34 | 2.3467 | 2.1523 | 2.26 | 97,600 |
| 02/02/26 | 2.37 | 2.43 | 2.34 | 2.34 | 47,076 |
| 30/01/26 | 2.36 | 2.41 | 2.24 | 2.40 | 141,396 |
|
|
||||
|
|
||||
|
|